NVNO
enVVeno Medical CorporationNASDAQHealthcare$10.53+0.00%ClosedMarket Cap: $173,777
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.23
P/S
0.00
EV/EBITDA
0.11
DCF Value
$3.46
FCF Yield
-8961.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-60.9%
ROA
-65.9%
ROIC
-75.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-4.0M | $-3.7M | $-5.91 | — |
| FY 2025 | $0.00 | -Infinity% | $-20.9M | $-19.5M | $-33.06 | — |
| Q3 2025 | $0.00 | -Infinity% | $-4.9M | $-4.5M | $-281.75 | — |
| Q2 2025 | $0.00 | -Infinity% | $-7.0M | $-6.7M | $-404.25 | — |
| Q1 2025 | $0.00 | -Infinity% | $-5.0M | $-4.5M | $-269.50 | — |
| Q4 2024 | $0.00 | -Infinity% | $-6.7M | $-6.2M | $-379.75 | — |
| FY 2024 | $0.00 | -Infinity% | $-23.8M | $-21.8M | $-1,555.75 | — |
| Q3 2024 | $0.00 | -Infinity% | $-6.2M | $-5.6M | $-428.75 | — |
| Q2 2024 | $0.00 | -Infinity% | $-5.5M | $-5.0M | $-379.75 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.5M | $-5.0M | $-379.75 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.3M | $-5.6M | $-514.50 | — |
| FY 2023 | $0.00 | -Infinity% | $-25.2M | $-23.5M | $-2,339.75 | — |